You are here

R&D

Merck KGaA links with AI firm to iron out side-effects during R&D

Pharmaforum

Mon, 12/10/18 - 09:56 am

artificial intelligence

drug development

In the wake of deep R&D cuts, Bayer flags safety concerns for a top PhIII drug

Endpoints

Wed, 12/5/18 - 09:50 am

uterine fibroids

Takeda Acquisition Of Shire May Bode Well For R&D Staff

Forbes

Mon, 12/3/18 - 10:05 am

BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation

Businesswire

Thu, 11/29/18 - 10:19 am

Ireland and Industry Leaders Announce $400 Million Program to Create Genomic Research Hub

CP Wire

Wed, 11/28/18 - 10:01 am

genome sequencing

Utah researchers get federal funds to study nonaddictive alternatives to opioids

KSL.com

Sun, 11/25/18 - 07:59 pm

University of Utah

UT Researchers Discover Alzheimer's Vaccine, Hope To Test In Humans Soon

Forbes

Sun, 11/25/18 - 07:56 pm

Alzheimer's disease

University of Texas

Lonza opens new research center in Israel

GoinPharma

Sun, 11/25/18 - 07:53 pm

Novartis CEO Is Going All in With Some Big Bets on R&D

BioSpace

Wed, 11/21/18 - 12:18 pm

Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks

BioSpace

Thu, 11/15/18 - 10:46 am

drug development

Boehringer Ingelheim

Healthcare will outspend all other industries on R&D by 2020, PwC says

Biopharma Dive

Tue, 11/13/18 - 10:11 pm

Harvard gets $200M gift to accelerate early-stage R&D

Fierce Biotech

Fri, 11/9/18 - 11:36 am

Merrimack cuts 60% of jobs, narrows R&D focus

Biopharma Dive

Wed, 11/7/18 - 10:36 pm

Merrimack Pharmaceuticals

Novartis Plans for 60 Regulatory Filings Over the Next Three Years

BioSpace

Tue, 11/6/18 - 09:41 am

drug development

New prize offers $2 million for finding key to Alzheimer’s in past research

Stat

Mon, 11/5/18 - 11:32 am

Alzheimer's disease

drug development

Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs

Xconomy

Thu, 11/1/18 - 12:22 pm

Denali Therapeutics

Alzheimer's disease

GSK tosses a trio of clinical-stage drugs on trial failures, winnowing out its respiratory pipeline as cancer moves to center stage

Endpoints

Wed, 10/31/18 - 11:51 am

drug development

clinical trials

Novartis Cuts 20% of Drug-Research Projects After Review

Bloomberg

Tue, 10/30/18 - 12:12 pm

drug development

How an outsider in Alzheimer’s research bucked the prevailing theory — and clawed for validation

Stat

Mon, 10/29/18 - 09:33 am

Alzheimer's disease

Merck KGaA says might strike partnership deal this year

Yahoo/Reuters

Sun, 10/21/18 - 11:43 pm

Pages